Skip to content

Clinical trials

Phase 3 Peripheral Arterial Disease trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Arterial Disease Phase: Phase 3 Country / region: Austria Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20112
20151
20171
20181
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Boston Scientific Corporation1
CSL Behring1
Eli Lilly and Company1
Eurocor GmbH1
Medical University of Vienna1
Novo Nordisk A/S1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Arterial Disease9
Atherosclerosis3
Cardiovascular Diseases2
Coronary Artery Disease2
Diabetes Mellitus, Type 22
Heart Diseases2
Peripheral Vascular Diseases2
Acute Coronary Syndrome1
Arterial Occlusive Diseases1
Atrial Fibrillation1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.